凯莱英 (002821)

Asymchem Laboratories (Tianjin) Co., Ltd.

ASZ

Tags

Contract Research Organization (CXO)MSCI Mid Cap IndexCSI 200 IndexInnovative DrugsMedical ServicesSynthetic BiologyContains H-SharesGuozheng Growth IndexFund Reduction PositionsFund Heavy PositionsEmerging Markets IndexOverseas BusinessHigh-Performing StocksNon-Cyclical StocksSME 300 IndexShenzhen ConnectSZSE 100 IndexSZSE 300 IndexSZSE Growth IndexTech 100 IndexPharma & BiotechTechnology Leaders IndexConsumer Services IndexSME Board Emerging IndexSZSE Medicine Equal Weight IndexSME Board High Beta IndexSZSE 100 Equal Weight IndexMid-cap High Beta IndexZhongchuang Equal Weight IndexCSI Emerging Industries IndexShenzhen A-Share Pharmaceutical IndexBOC International CSI 300 ESG IndexCS High Dividend Yield IndexCSI All-share Pharmaceutical Sector IndexSZSE Emerging Industries IndexZhongchuang Growth IndexSME Board Equal Weight IndexSZSE 300 Return IndexCSSW Health IndexCSI 1000 Growth IndexSZSE Component Index ReturnCSI 300 Equal Weight IndexCSI 300 ESG IndexLarge & Mid-cap IndexCNI 1000 IndexXingyin Wealth Management Balanced 300 IndexCS Beijing-Tianjin-Hebei IndexBiomedicine IndexCSSW Silk Road IndexCSI Medical IndexCS Precision Medicine IndexZhongchuang Value IndexArtemisininFTSE Russell ConceptSeptember 2021 Lock-up ExpiryJune 2021 Lock-up ExpiryCSI 300 Non-cyclical IndexTechnology 50 IndexSME Board Composite IndexSZSE Selected IndexCS High-end Manufacturing IndexCSI 300 Shenzhen Market IndexZhongchuang 100 Return IndexSZSE Technology IndexCSI 300 ESG Leading IndexSZSE 100 Return IndexSHS Innovative Drugs IndexSZSE High Beta IndexSZSE ChiNext 100 IndexSustainable Development IndexCSI 300 Growth IndexSecurities Times Value 100 IndexSZSE Pharmaceutical IndexCSI 800 IndexCS Pharmaceutical TI Index100 Performance IndexESG 100 IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexCNI 300 IndexCCTV 500 IndexCSI 300 USD (CNH) IndexCS Pharmaceutical Innovation IndexSZSE Component Pharmaceutical IndexPharmaceutical Sub-sector IndexCSI All-share Pharmaceutical IndexCSI 300 USD IndexSZSE Pharmaceutical 50 IndexSmart Select 300 ESG Leading IndexSZSE 300 Equal Weight IndexCSI 500 Equal Weight IndexCSI 800 Pharmaceutical IndexSZSE Component Index Equal WeightCS Biomedicine IndexPharmaceutical & Health 100 IndexInnovative Drugs 30 IndexCSI 300 Pharmaceutical IndexSME Board Performance IndexSME & ChiNext Q IndexCSI 700 IndexAH Economic Blue-chip IndexMid-small Cap IndexCSI 500 IndexPharmaceutical 50 IndexZhongchuang High Beta IndexZhongchuang Low Volatility IndexPharmaceutical 50 Strategy IndexCSI Life Sciences IndexSZSE 200 Return IndexSZSE 200 IndexZhongchuang 400 IndexCS Innovative Drugs IndexESG 300 IndexCR New Momentum IndexOrient Securities Competition IndexChina Economic Index GDPJuchao Mid-cap IndexCSI 1000 Value IndexSZSE 500 IndexCSI 300 Growth Innovation IndexCSI 500 ESG IndexStrategic Emerging Industries 100 IndexTianjin

K-Line Chart

No K-line data available

Company NameAsymchem Laboratories (Tianjin) Co., Ltd.
Listing Date2016-11-18
Issue Price30.53RMB
Registered Capital36059.37210k RMB
Legal RepresentativeHAO HONG
Registered AddressNo. 6, Dongting Third Street, Tianjin Economic-Technological Development Area
IndustryMedical Services
Main BusinessThe company's main business revenue can be categorized into two types by business segment: sales of goods and provision of services.
Company ProfileAsymchem Laboratories Group is a leading enterprise in China's pharmaceutical services industry. Founded in 1998 by Dr. Hao Hong in the Tianjin Economic-Technological Development Area, the company is dedicated to technological innovation and commercial application in global pharmaceutical processes. It provides one-stop drug R&D and production services to pharmaceutical companies, including the world's top ten pharmaceutical corporations. Over the years, the company has established six subsidiaries in China, holds over 60 invention patents, and has successfully secured numerous national and provincial/municipal projects such as the National Major New Drug Creation Program, the National 863 Program, Tianjin's 'Mayor's Fund' Project, Tianjin's Independent Innovation Industrialization Project, and Tianjin's Major High-Tech Industrialization Project. It has also been awarded the 'Primary Supplier Award' by Merck, the 'Best Intermediate Contract Manufacturer Award' by Pfizer, and the 'Most Valuable Partner' award by Roche.

Stock Details

1. Key Indicators

  • Total Shares(W): 36059.37
  • Circulating A-Shares(W): 31699.99
  • Earnings Per Share(RMB): 2.1800
  • Net Assets Per Share(RMB): 48.1160
  • Operating Revenue(W RMB): 462987.71
  • Total Profit(W RMB): 90994.91
  • Net Profit Attributable to Parent(W RMB): 80024.52
  • Net Profit Growth Rate(%): 12.66
  • Weighted Return on Equity(%): 4.63
  • Operating Cash Flow Per Share(RMB): 3.1730
  • Undistributed Profit Per Share(RMB): 23.5256
  • Capital Reserve Per Share(RMB): 24.1053

2. Main Business

The main business covers:

  • Providing a full life-cycle one-stop service for domestic and foreign pharmaceutical companies and biotechnology companies.

3. Company Basic Information

  • Company Name: Asymchem Laboratories (Tianjin) Co., Ltd.
  • Listing Date: 2016-11-18
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 71, 7th Avenue, Tianjin Economic-Technological Development Area, Tianjin, China
  • Website: www.asymchem.com.cn
  • Company Profile: The company was established through the overall change of Asymchem Laboratories (Tianjin) Co., Ltd. It provides a full life-cycle one-stop service for domestic and foreign pharmaceutical companies and biotechnology companies.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 ASYMCHEM LABORATORIES, INCORPORATED General Legal Person 11513.32 36.32
2 China Europe Healthcare Hybrid Securities Investment Fund A Fund 1631.90 5.15
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 1328.77 4.19
4 Tianjin Guorong Business Information Consulting Co., Ltd. General Legal Person 637.66 2.01
5 Huabao CSI Healthcare ETF Fund 564.67 1.78
6 China Europe Healthcare Innovation Equity Securities Investment Fund A Fund 487.80 1.54
7 Asymchem Laboratories (Tianjin) Co., Ltd. - 2022 Employee Stock Ownership Plan General Legal Person 318.28 1.00
8 China Merchants CSI Bio-medicine Index Securities Investment Fund (LOF) A Fund 293.60 0.93
9 Tianhong Pharmaceutical Innovation Hybrid Securities Investment Fund A Fund 90.28 0.28
10 China Merchants Healthcare Industry Equity Securities Investment Fund Fund 70.53 0.22

5. Concept Sectors

  • H-Share
  • CXO Concept
  • Innovative Drug
  • Weight Loss Drug
  • Synthetic Biology
  • Margin Trading & Securities Lending
  • High-Performance Stock
  • Fund Heavy Holdings
  • MSCI Mid Cap
  • Overseas Business
  • Fund Reducing Holdings
  • Non-Cyclical Stock
  • SME 100
  • Mid Cap Growth
  • SZSE 300
  • Technology 100
  • SZSE Growth
  • SME 300
  • SZSE Innovation

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information